SYNDAX
Live / Registered — Registered and renewed (as of 02 Apr 2026)
What this means for you
Registered since 08 Dec 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Dec 2025).
Record
- Serial number
- 86392710
- Registration number
- 4867989
- Mark type
- Stylized text
- Filed
- 11 Sept 2014
- Published for opposition
- 17 Feb 2015
- Registered
- 08 Dec 2015
- Next maintenance due
- 08 Dec 2025
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Syndax Pharmaceuticals, Inc., Waltham, MA, US
- Syndax Pharmaceuticals, Inc., Waltham, MA, US
- Syndax Pharmaceuticals, Inc., Waltham, MA, US
Prior registrations
Prosecution history
- 02 Apr 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 02 Apr 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 02 Apr 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Apr 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Jan 2026 — TEAS SECTION 8 & 9 RECEIVED
- 19 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 May 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 21 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 08 Dec 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Jun 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Dec 2021 — TEAS SECTION 8 & 15 RECEIVED